Cellanome IPO

cellanome.com

Cellanome is a developer of a multiomics platform that prusues increased clarity and resolution to help develop new therapies for complicated biological issues.

Founded2020
Total Funding to Date$56.3MM
Register for Details

For more details on financing and valuation for Cellanome, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Cellanome Ticker Symbol

Cellanome does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Cellanome Stock Price

The stock price for Cellanome will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Cellanome Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/25/2022 Series A-2 $30.62MM raised $XXX.XX $XXX.XX
12/8/2021 Series A $21MM raised $XXX.XX $XXX.XX
9/17/2021 Series Seed and Seed 2 $4.67MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Cellanome in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector